Innovating Better Health

Watch how ERT pushes the needle in clinical research innovations

WATCH

ERT eCOA Rater Training

Electronic Rater Training for Site Staff/Clinicians (ClinRO),
Caregivers (ObsRO), Proxy Reporters and Subjects (PRO)

Request a Demo

ERT Insights Cloud

Delivering Real-time Insights Across
All of Your Clinical Trial Data

Learn More

Reduce Site Burden

Optimize ECG and Clinical Outcome Assessments
with One Integrated Tablet Solution

Learn More

Meet MasterScope 2.0

The New, All-In-One Respiratory &
Multi-Endpoint Trial Platform

Learn More

ERT Site Selection

Leverage data from over 40,000 sites and millions of
endpoints to select only the highest performing sites for your next study.

Learn More

SOLUTIONS

ERT is the leading cloud platform solutions provider that captures quality efficacy and safety endpoints, harmonizes data from any clinical source system, and delivers real-time insights for optimum trial performance.

LOOKING FOR OUR HEALTHCARE SOLUTIONS?

ABOUT ERT

ERT is a software enabled solutions provider with over 40 years of experience collecting clinical efficacy and safety endpoints with the ultimate goal of innovating better health.

8300
Studies
173000
Sites
2600000
Patients
450
Drug Approvals

SIGN UP FOR OUR NEWSLETTER

LATEST NEWS

EVENTS

Asian Regional Drug Development Summit 2015

|
Join Dr. Robert Kleiman on Wednesday, September 9, 2015 at 11:30 am for his session: Cardiac Safety in Early Clinical Development – State of the Art Cardiac safety issues affecting non-cardiac...
Read More

Outsourcing in Clinical Trials – Nordics

|
Stop by and visit us at stand 11. For more information, please visit here. September 9-10, 2015 Crowne Plaza Copenhagen Towers Ørestads Boulevard 114-118, DK- 2300 Copenhagen, Denmark
Read More

Outsourcing in Clinical Trials – New England

|
Stop by and visit us at booth 34. For more information, please visit here. September 16-17, 2015 Sheraton Boston Hotel 39 Dalton Street Boston, MA 02199
Read More

SCDM

|
Join Nick Neri on Monday, September 21 from 10:30 am - 12:00 pm for his session entitled: Should this Data Be Integrated? Stop by and visit us at booth 204....
Read More

2015 PRO & eCOA Congress – Lisbon

|

Attend an exclusive two-and-a-half day PRO and eCOA Congress, which will be held in Lisbon, Portugal 22-24 September, 2015. The Congress is the industry’s foremost PRO & eCOAs event designed…


Read More

European Respiratory Society (ERS) International Congress

|
Stop by and visit us at booth 1.E_05. The following posters will be presented based on work conducted by and/or supported by ERT: -        Laura Khurana, MPH, ERT Scientific Advisor...
Read More

2015 PRO & eCOA Congress – D.C.

|

Attend an exclusive two-and-a-half day PRO and eCOA Congress, which will be held in Washington, D.C. 27-29 October, 2015. The Congress is the industry’s foremost PRO & eCOAs event designed…


Read More

ISPOR 18th Annual European Congress

|
For more information, please visit here. November 9-11, 2015 MICo - Milano Congressi Piazzale Carlo Magno, 1-20149 Milan, Italy
Read More

Partnerships in Clinical Trials Congress 2015

|
Stop by and visit us at stand 315. For more information, please visit here. November 17-19, 2015 CCH-Congress Center Hamburg Am Dammtor / Marseiller Strasse 20355 Hamburg Germany
Read More

WEBINARS

Reporting vs. Analytics: Changing Your Clinical Research Paradigm Through Actionable Insights

Industry buzzwords like Big Data and Risk-based Monitoring are dominating industry forums, and clinical research organizations are exploring how they can leverage data analytics to change the paradigm of their...
Read More

Future of Cardiac Safety in Clinical Development

This webinar will be conducted entirely in Japanese. There may be some confusion about the future of cardiac safety in drug development. While the pharmaceutical industry’s approach based on ICH...
Read More

臨床開発における心臓安全性の将来展望

医薬品開発における心臓安全性評価の将来について様々な議論が行われています。ICH E14やTQT試験に基づく製薬業界の取り組みはトルサド・ド・ポアンや致命的な不整脈の発生リスクを軽減してきましたが、その一方で、2013年以降の臨床初期試験でのPK/PD分析を用いた新手法の導入は新たな議論を呼んでいます。本講演では、心臓安全性の基本理解をさらに掘り下げ、新しいコンセプトと臨床試験デザインを左右する様々な要素について解説いたします。また、心臓安全性を扱う臨床試験での取り組みの実際的な運用法と制限についてお話しするとともに、先日完了したFDAのTQT民族間比較試験についても解説いたします。   2015年9月24日(木)午前11時 1時間 登録する
Read More

eCOA and Trial Design Considerations in Gastrointestinal Therapeutic Indications (including gastroparesis, GERD, IBD, IBS, and Celiac disease)

Each month, the ERT Endpoints to Insights Webinar Series will focus on different aspects of effective endpoint data collection and on-demand analytics for clinical trials and healthcare. For the September...
Read More

Gender and Phase I Data as Factors in the Design of a Thorough QT Study: Results of the FDA Ethnicity Trials and Current Issues Impacting Cardiac Safety Research

Potential refinements in the conduct of Thorough QT (TQT) studies to assess the cardiac safety of new drugs have emerged based on new data and evolving regulatory perspectives. A recent...
Read More

WANT TO LEARN MORE?